Sparlon Is In Strattera Stratum With Regard To Efficacy, Committee Says
Executive Summary
Efficacy of Cephalon's attention deficit/hyperactivity disorder drug Sparlon should be considered to be in the range of Lilly's Strattera, FDA's Psychopharmacologic Drugs Advisory Committee said March 23